[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-1-en-105":3,"doc-seo-393342-105":53,"doc-detail-393342-en":126},{"code":4,"msg":5,"data":6},0,"success",[7,14,19,24,29,34,39,44,49],{"id":8,"doc_module":9,"doc_module_name":10,"category_name":11,"show_sort_weight":12,"slug":13},11,1,"Template","Presentations",90,"presentations",{"id":15,"doc_module":9,"doc_module_name":10,"category_name":16,"show_sort_weight":17,"slug":18},12,"Resumes",80,"resumes",{"id":20,"doc_module":9,"doc_module_name":10,"category_name":21,"show_sort_weight":22,"slug":23},14,"Invoices",70,"invoices",{"id":25,"doc_module":9,"doc_module_name":10,"category_name":26,"show_sort_weight":27,"slug":28},15,"Posters",60,"posters",{"id":30,"doc_module":9,"doc_module_name":10,"category_name":31,"show_sort_weight":32,"slug":33},16,"Social Media",50,"social-media",{"id":35,"doc_module":9,"doc_module_name":10,"category_name":36,"show_sort_weight":37,"slug":38},17,"Forms",40,"forms",{"id":40,"doc_module":9,"doc_module_name":10,"category_name":41,"show_sort_weight":42,"slug":43},18,"Letters",30,"letters",{"id":45,"doc_module":9,"doc_module_name":10,"category_name":46,"show_sort_weight":47,"slug":48},21,"Paper Templates",5,"papers-templates",{"id":50,"doc_module":9,"doc_module_name":10,"category_name":51,"show_sort_weight":4,"slug":52},158,"General","general-158",{"code":4,"msg":54,"data":55},"ok",{"site_id":56,"language":57,"slug":58,"title":59,"keywords":60,"description":61,"schema_data":62,"social_meta":119,"head_meta":121,"extra_data":123,"updated_unix":125},105,"en","open-gold-copd-exacerbation-treatment-guidelines","Open Gold COPD Exacerbation Treatment Guidelines","","COPD exacerbation management guidance outlines diagnostic suspicion, including maintaining a high index of suspicion for COVID-19 when COPD patients present with exacerbation symptoms accompanied by fever, taste or smell impairment, or gastrointestinal complaints. Follow-up pharmacologic care follows a first review-and-assess approach: reassess symptoms and exacerbation risk, evaluate inhaler technique and adherence, and adjust therapy with escalation or de-escalation as needed. Antibiotics are recommended when indicated, aiming to shorten recovery, reduce early relapse and treatment failure, and limit hospitalization duration. Guidance also covers treatment duration, bronchodilators, systemic corticosteroids, transition to maintenance therapy, and supportive planning for oxygen and basic necessities.",{"@graph":63,"@context":118},[64,80,101],{"@type":65,"itemListElement":66},"BreadcrumbList",[67,71,74,77],{"item":68,"name":69,"@type":70,"position":9},"https://docshare.wps.com","Home","ListItem",{"item":72,"name":10,"@type":70,"position":73},"https://docshare.wps.com/template/",2,{"item":75,"name":11,"@type":70,"position":76},"https://docshare.wps.com/template/presentations/",3,{"item":78,"name":59,"@type":70,"position":79},"https://docshare.wps.com/template/open-gold-copd-exacerbation-treatment-guidelines/393342/",4,{"url":78,"name":59,"@type":81,"image":82,"author":87,"headline":59,"publisher":90,"fileFormat":93,"inLanguage":57,"description":61,"dateModified":94,"datePublished":95,"encodingFormat":93,"isAccessibleForFree":96,"interactionStatistic":97},"DigitalDocument",{"url":83,"@type":84,"width":85,"height":86},"https://docshare.wps.com/thumbnails/open-gold-copd-exacerbation-treatment-guidelines/393342.png","ImageObject",442,249,{"name":88,"@type":89},"anakgang17","Person",{"url":68,"name":91,"@type":92},"DocShare","Organization","application/pdf","2026-10-22","2026-09-26",true,{"@type":98,"interactionType":99,"userInteractionCount":47},"InteractionCounter",{"@type":100},"ViewAction",{"@type":102,"mainEntity":103},"FAQPage",[104,110,114],{"name":105,"@type":106,"acceptedAnswer":107},"How should follow-up pharmacological management for COPD exacerbations be conducted?","Question",{"text":108,"@type":109},"Use a first review and assess approach, then adjust if needed. Review symptoms and exacerbation risk, assess inhaler technique and adherence, and adjust pharmacologic treatment with escalation or de-escalation.","Answer",{"name":111,"@type":106,"acceptedAnswer":112},"When are antibiotics recommended in COPD exacerbations?",{"text":113,"@type":109},"Antibiotics are used when indicated to shorten recovery, reduce early relapse and treatment failure, and decrease hospitalization duration. This applies regardless of evidence of SARS-CoV-2 infection.",{"name":115,"@type":106,"acceptedAnswer":116},"What is the purpose of bronchodilators and systemic corticosteroids during an acute COPD exacerbation?",{"text":117,"@type":109},"Short-acting inhaled beta2-agonists (with or without short-acting anticholinergics) are recommended as initial bronchodilators. Systemic corticosteroids improve lung function, oxygenation, and shorten recovery time and hospitalization duration.","https://schema.org",{"og:url":78,"og:type":120,"og:title":59,"og:site_name":91,"og:description":61},"article",{"robots":122,"canonical":78},"index,follow",{"doc_id":124,"site_id":56},393342,1791728942,{"code":4,"msg":5,"data":127},{"doc_id":124,"user_id":128,"nickname":88,"user_avatar":129,"doc_module":9,"category_id":8,"category_name":11,"doc_title":59,"doc_description":61,"doc_content":130,"file_id":131,"file_url":132,"file_type":133,"file_size":134,"view_count":47,"is_deleted":4,"is_public":9,"is_downloadable":9,"audit_status":9,"page_count":79,"language":135,"language_code":57,"site_id":56,"html_lang":57,"table_of_contents":136,"faqs":137,"seo_title":138,"seo_description":61,"update_tm":139,"read_time":73},962090883568,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Open  \nGold copd exacerbation treatment guidelines  \nGold copd guidelines treatment. Who gold copd guidelines.  \nThe prodrome of milder symptoms is especially problematic in patients with underlying COPD who may already have diminished lung reserve A high index of suspicion for COVID-19 needs to be maintained in patients with COPD who present with symptoms of an exacerbations, especially if accompanied by fever, impaired taste or smell or gastrointestinal complaints. As the value of gold becomes higher than a miner’s cost of production, profitability moves up dramatically. Follow up pharmacological management should be guided by the principles of first review and assess, then adjust if needed: review review symptoms (dyspnea) and exacerbation risk assess assess inhaler technique and adherence, and the role of non-pharmacological approaches (covered later in this chapter) adjust adjust pharmacological treatment, including escalation or de-escalation. Plans should be made to ensure supplies of food, medications, oxygen, supportive health services and other basic necessities can be maintained. Antibody testing maybe used to support clinical assessment of patients who present late. Duration of therapy should not be more than 5–7 days Antibiotics, when indicated, can shorten recovery time, reduce the risk of early relapse, treatment failure, and hospitalisation duration. If a change in treatment is considered necessary then select the corresponding algorithm fordyspnoea (see Algorithm 4, left column) or exacerbations (see Algorithm 4, right column); the exacerbation algorithm should also be used for patients who require a change in treatment for both dyspnoea and exacerbations. One-, 10-and 100-ounce bars are popular. Physicians should emphasize the importance of a smoke free environment, prescribe vaccinations, empower adherence to prescribed medication, ensure proper inhaler technique, promote physical activity and refer patients (GOLD B—GOLD D) to pulmonary rehabilitation Some relevant non-pharmacological measures based on the GOLD group AT DIAGNOSIS are summarised in Table 2. Patients should be encouraged to increase the level of physical activity although we still don’t know how to best ensure the likelihood of success. For information on remote COPD patient follow-up during COVID-19 pandemic restrictions, refer to the full guideline. Patient groupEssentialRecommendedDepending on local guidelines A Smoking cessation (can include pharmacological treatment) Physical activity Flu vaccination Pneumococcal vaccination Pertussis vaccination B, C, and D Smoking cessation (can include pharmacological treatment) Pulmonary rehabilitation Physical activity Flu vaccination Pneumococcal vaccination Pertussis vaccination [A] Can include pharmacological treatment © Global Initiative for Chronic Obstructive Lung Disease, 2020. In patients with FEV1/FVC \u003C 0.70: GOLD 1—mild: FEV1≥ 80% predicted GOLD 2—moderate: 50% ≤ FEV1 \u003C 80% predicted GOLD 3—severe: 30% ≤ FEV1 \u003C 50% predicted GOLD 4—very severe: FEV1 \u003C 30% predicted. Whilst case rates are high, centre-based rehabilitation is not appropriate. Interventional bronchoscopy and surgery An exacerbation of COPD is defined as an acute worsening of respiratory symptoms that results in additional therapy As the symptoms are not specific to COPD relevant differential diagnoses should be considered Exacerbations of COPD can be precipitated by several factors. COPD often coexists with other diseases (comorbidities) that may have a significant impact on disease course In general, the presence of comorbidities should not alter COPD treatment and comorbidities should be treated per usual standards regardless of the presence of COPD Cardiovascular diseases are common and important comorbidities in COPD Lung cancer is frequently seen in patients with COPD and is a major cause of death Osteoporosis and depression/anxiety are frequent, important comorbidities in COPD, are often under diagnosed, and are associat","cbCaihOHn4L5WPWe","https://ap.wps.com/l/cbCaihOHn4L5WPWe","pdf",328794,"English","# GOLD COPD management\n## Follow-up pharmacological management\n## Non-pharmacological measures at diagnosis\n## Exacerbation definition and differential diagnoses\n## Comorbidities in COPD\n## Pharmacological treatment goals and step-up/step-down","[{\"question\":\"How should follow-up pharmacological management for COPD exacerbations be conducted?\",\"answer\":\"Use a first review and assess approach, then adjust if needed. Review symptoms and exacerbation risk, assess inhaler technique and adherence, and adjust pharmacologic treatment with escalation or de-escalation.\"},{\"question\":\"When are antibiotics recommended in COPD exacerbations?\",\"answer\":\"Antibiotics are used when indicated to shorten recovery, reduce early relapse and treatment failure, and decrease hospitalization duration. This applies regardless of evidence of SARS-CoV-2 infection.\"},{\"question\":\"What is the purpose of bronchodilators and systemic corticosteroids during an acute COPD exacerbation?\",\"answer\":\"Short-acting inhaled beta2-agonists (with or without short-acting anticholinergics) are recommended as initial bronchodilators. Systemic corticosteroids improve lung function, oxygenation, and shorten recovery time and hospitalization duration.\"}]","Open Gold COPD Exacerbation Treatment Guidelines | PDF",1790384087]